Gensia Inc. sales and marketing update

The company's loss increased to $17.8 million (68 cents per share) on revenues of $6.8 million in the third quarter ended Sept. 30. The loss in the 1992 quarter was $9.7 million (35 cents) on revenues of $10.4 million. The current period results reflected a $4.1 million decline in contract revenue with the completion of funding from Gensia Clinical Partners L.P., and a $3.1 million increase in R&D expense. Product sales were $3.9 million compared with $3.2 million in the quarter last year. ...